SEARCH

NEWS

Eurofins makes £4 million investment in new Scottish facility

Published: October 30, 2017

Eurofins Scientific, a world leader in bioanalytical testing, has opened a new pharmaceutical chemistry and microbiology facility in Livingston, Scotland, following a £4 million investment.

Sterling invests £6m in milling micronization and solid form facility

Published: October 30, 2017

Contract development and manufacturing organisation (CDMO) Sterling Pharma Solutions is investing £6m into a new facility at its UK site to strengthen and expand its milling, micronization and solid form capabilities. The 40-acre site in Dudley, North East England, will meet growing demand for pharmaceutical API particle size control technology, as well as expanding Sterling’s laboratory capabilities to provide a full solid form offering including polymorph screening, salt selection and particle engineering and crystallization scale-up.

AkzoNobel tops CDP chemicals ranking

Published: October 30, 2017

AkzoNobel has been ranked number one on the influential CDP (Carbon Disclosure Project) Global Chemical Companies List, which ranks the largest publicly listed chemical companies on business readiness for a low carbon transition. The results are published in the Catalyst for change report, which focuses on a group of 22 companies responsible for a combined total of 276 million metric tons of CO2 emissions a year – which represents a quarter of all annual emissions in the chemicals sector.

Thomas Swan acquires US manufacturing facility

Published: October 30, 2017

Thomas Swan & Co has completed the purchase of the Opelika, Alabama speciality chemicals manufacturing facility formerly owned by Apollo Chemicals, part of Mt Vernon Chemicals group.

Chemical company benefits from manufacturing optimism

Published: October 30, 2017

Airedale Chemical, a Yorkshire-based chemical specialist, has seen sales of one of its key products soar due to its use in the strengthening manufacturing sector. Airedale Chemical is celebrating a 40% rise in production output this year to date for one of its own-branded chemicals. Airquest, a family of phosphonate-based products, are widely used in elements of many manufacturing processes and the resurgence of the UK manufacturing industry has led to a rise in demand from customers.

SeaPoint: a unique industrial deepwater site

Published: October 30, 2017

The SeaPoint Industrial Terminal Complex was unveiled in October 2017 – a mile-long private deepwater frontage along the main Savannah River shipping channel, as well as class I rail service on-site and easy access to the Georgia Ports Authority and major interstates like I-95 and I-16. Located on the site of the former Kemira plant in Savannah, GA (USA), SeaPoint is a unique industrial deepwater site for the Southeast US. Greenfield, a brownfield redevelopment company, took over the site after the Tronox bankruptcy in 2009. The 755-acre site will include use of an existing office complex, warehousing, security, rail, deep water terminal operations, by-product steam, logistical services, maintenance services and more.

U.S. Water wins court battle

Published: October 27, 2017

According to U.S. Water, a federal jury in the Western District of Wisconsin has delivered a unanimous verdict in favour of U.S. Water in its lawsuit against Novozymes A/S and Novozymes North America, Inc.The jury found that Novozymes’s sale of Phytaflow to its customers caused infringement of the U.S. Water patents asserted in that case, U.S. Patent Nos. 8,415,137 and 8,609,399, relating to U.S. Water’s pHytOUT deposit control technology and that these patents are valid.The jury awarded U.S. Water $7.58 million dollars in past damages for the infringement.

CPhI Worldwide announces the winners of 2017 Pharma awards

Published: October 27, 2017

The 2017 CPhI Pharma Award winner by category:

SABIC showcasing resins and development services at Aquatech

Published: October 16, 2017

SABIC will highlight new predictive engineering capabilities of its Water Management Centre of Excellence, and compelling new data on anti-biofouling performance, at Aquatec Amsterdam 2017.

Pertinax Pharma: new patented chlorhexidine technology

Published: October 16, 2017

Pertinax Pharma has launched its patented chlorhexidine technology – Pertinax. Novel materials enable controlled and sustained release of chlorhexidine across a multitude of applications Pertinax Pharma has announced the commercial launch of its unique, proprietary Pertinax technology, which provides controlled and sustained delivery of chlorhexidine (CHX). The new technology has a wide range of potential applications across the wound care, dentistry, medical device and veterinary markets.

HOME | NEWS | FEATURES | MAGAZINE | ABOUT | CONTACT | COOKIES

Copyright © 2017 Mack Brooks Speciality Publishing.